newsfilter
← Latest News
PR Newswire·

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the...